Intimation of Grant of stock options under Marksans Employee Stock Option Scheme 2024
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Marksans Pharma has announced the grant of 3,00,000 stock options to eligible employees under its Employees Stock Option Scheme 2024. The options have an exercise price of Rs. 10 per option and can be exercised within 2 years after vesting. The vesting period is 1 year from the grant date of May 25, 2026. If exercised, this would result in 3,00,000 equity shares of Re. 1 face value each being issued. The scheme is compliant with SEBI's Share Based Employee Benefits Regulations, 2021.
This ESOP grant aligns employee interests with shareholders but causes dilution. The Rs. 10 exercise price is significantly below the likely market price, which is positive for employees but could have a minor negative impact on existing shareholders due to potential dilution.